Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Borealis Biosciences Address
null, null United States
Borealis Biosciences Email
Past Companies
Sana Biotechnology, Inc.Executive Vice President, Chief Business Officer
Juno Therapeutics, Inc.Vice President, Myeloma Program Lead
Juno Therapeutics, Inc.Vice President, Head of Business Development